
Sign up to save your podcasts
Or


Based on Podcast App listening data
Episode Description:
This is a From the Archive episode with one of my favorite guests: Steven Pressfield.
Steven Pressfield has spent his career writing about war, creativity, discipline, storytelling, and the inner battle every artist faces. In this archive conversation, James and Steven explore how stories work—and why the same structures that power novels and movies also show up in real life.
They begin with The Legend of Bagger Vance, which Pressfield built from the structure of the Bhagavad Gita. James connects that idea to his own writing, where ancient texts like the Yoga Sutras became frameworks for modern essays about entrepreneurship. Their point is simple: if a story has survived thousands of years, it probably contains a structure worth studying.
From there, the conversation moves into the hero’s journey. The ordinary world. The call to adventure. The refusal of the call. The mentor. The threshold. The extraordinary world. The tests, allies, enemies, ordeal, return, and gift.
But Pressfield pushes the idea further. In real life, people do not always answer the call. Some people refuse it for years. Some cross the threshold and then run back. Some sacrifice security, status, money, family expectations, or even relationships to follow the deeper pull of their lives.
James shares his own story of walking out of a finance job after three days, leaving his coat on the chair, taking the elevator down 40 floors, getting on a train, and never returning. Pressfield recognizes it immediately as a real-life threshold moment.
The conversation then turns to The Artist’s Journey. Pressfield explains that the hero’s journey ends when the hero returns home with a gift. The artist’s journey begins when the artist asks: What is the gift I am meant to give? What is my material? What is my voice? What am I here to make?
They discuss Resistance as the real villain in every story, why the question “Who am I?” often drives the inciting incident, why villains often do not change, why opening and closing images matter, and why genres have rules that writers ignore at their own risk.
This episode is a masterclass in story, but it is also a meditation on identity. The deeper question is not just how to write a story. It is how to recognize the story already trying to live through you.
Editorial Note:
This is a "From the Archive" episode. References to “new” or “upcoming” books, projects, or events reflect the timing of the original recording.
What You’ll Learn:
Timestamped Chapters:
Additional Resources:
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
A Note from James:
I’m doing a big experiment in my life.
I recently started taking a GLP-1—tirzepatide, one of the so-called weight-loss drugs. But I didn’t start taking it specifically for weight loss. I had some blood work done for the first time in a long time, and there was a small indication that I might be pre-diabetic. My doctor suggested trying tirzepatide, and I wanted to understand what I was getting into.
The first person I wanted to talk to was Charles Duhigg, author of The Power of Habit and Supercommunicators. Charles has been taking a GLP-1 for about two years, and he says it has changed his life. He has lost around 45 pounds, but what interested me most was not just the weight loss. It was the habit change.
Charles explains that GLP-1s can quiet what people now call “food noise”—the constant background pull toward eating even when you are not actually hungry. When that noise quiets down, something interesting happens: you get a window where your old habits become more malleable.
That is the key idea of this conversation. The drug may help you eat less, but the bigger opportunity is that it gives you a chance to build new routines around food, exercise, alcohol, sleep, and identity. And if you build those habits while the window is open, those habits may continue even after you stop taking the medication.
We talk about food noise, cravings, the habit loop, keystone habits, stated versus revealed preferences, placebo effects, alcohol, sleep, exercise, blood sugar, identity, and whether GLP-1s are a lifelong drug or a tool for changing who you become.
Episode Description:
James is at the beginning of a GLP-1 experiment. Charles Duhigg is two years in.
In this conversation, Charles explains what he has learned from taking tirzepatide and from studying GLP-1s through the lens of habit formation. He describes the first phase of public understanding around these medications as weight loss. Phase two, he argues, is about behavior change.
The central concept is “food noise.” Charles describes it as the background craving that turns a basket of fries into an almost automatic behavior. You may not even notice the noise until it goes away. Once it quiets, the cue that normally triggers the habit loop weakens. That creates a temporary window where new habits can be built.
James and Charles use the GLP-1 experience to revisit the basic habit loop: cue, routine, reward. They talk about why habits feel automatic, why willpower is often the wrong tool, and why successful behavior change depends on identifying the cue and replacing the routine while still satisfying the underlying reward.
Charles also introduces the idea of GLP-1s as a catalyst for keystone habits. Eating less can make exercise easier. Drinking less can improve sleep. Better sleep can improve focus. Focus can improve work. One changed habit can set off a chain reaction.
The conversation then becomes more philosophical: Who are we if one part of the brain says “I want to be healthy,” while another part of the brain keeps revealing different preferences through action? Charles explains the difference between stated preferences and revealed preferences, and how repeated behavior can shift identity.
This is not a conversation about taking GLP-1s casually. It is a conversation about using a medical intervention deliberately, under appropriate medical guidance, as a chance to change the patterns that shape daily life.
Editorial Note:
This episode discusses prescription medications, including tirzepatide and semaglutide, as well as personal experiences with GLP-1 drugs. It should not be treated as medical advice.
GLP-1 medications can have side effects and risks, including gastrointestinal symptoms, dosing concerns, and contraindications for some patients. They should be used only under the supervision of a qualified medical professional. Any decision to start, stop, adjust, or combine medications should be made with a clinician.
James and Charles also discuss personal experience, habit change, appetite, alcohol cravings, and identity. Individual responses to these medications vary.
What You’ll Learn:
Timestamped Chapters:
[03:36] James Begins His GLP-1 Experiment
James explains his early experience, including confusion between medication side effects and a bout of COVID.
[04:16] Charles’s Two-Year Experience
Charles describes taking tirzepatide, losing roughly 45 pounds, and why the biggest changes came months into the process.
[05:38] Phase One vs. Phase Two of GLP-1s
Phase one was about appetite and weight loss. Phase two, Charles argues, is about habits that can last.
[06:42] The Habit Window
How GLP-1s can quiet food noise and create a period where eating habits become more malleable.
[07:21] COVID, Side Effects, and Early Signals
James explains why his first few weeks were hard to interpret and why he is still figuring out what the medication is doing.
[09:00] What Food Noise Actually Feels Like
Charles uses the example of a basket of fries to explain cravings, cues, and automatic eating.
[09:55] The Habit Loop: Cue, Routine, Reward
Charles revisits the framework from The Power of Habit and applies it directly to food cravings.
[10:42] How GLP-1s Interrupt the Cue
The fries are still there, but the craving does not activate in the same way.
[11:40] What GLP-1s Do in the Body and Brain
Charles explains what researchers know about gastric emptying, glucagon-like peptides, and what remains uncertain about the brain.
[12:43] What Happens When You Stop
Why the medication alone may not be enough if old habits return after discontinuation.
[13:36] Pleasure, Food, Alcohol, and Anhedonia
Charles discusses reduced pleasure from food and alcohol, while separating clinical findings from broader claims about losing joy in life.
[15:54] Why Charles Stayed With It
Early changes were not dramatic weight loss, but a growing feeling that eating became more of a choice.
[16:40] Eating as a Keystone Habit
How changing food behavior can trigger changes in exercise, alcohol, sleep, focus, and work.
[19:31] Why Structure Matters
Charles explains why tracking and guided habit systems can help people see patterns they might miss on their own.
[20:32] What Changes Physically Over Time
Slower stomach emptying, feeling full longer, more stable blood sugar, and gradual changes in appetite.
[21:43] Stated Preferences vs. Revealed Preferences
Why one part of the brain says “I want to change,” while another part watches what you actually do.
[23:22] Identity Change and Habit Formation
How repeated behavior can teach the brain, “I am the kind of person who eats this way” or “I am the kind of person who exercises.”
[24:16] Placebo, Belief, and Becoming the Person You Want to Be
James and Charles explore whether placebo effects may work partly by changing identity.
[28:07] Alter Egos, Athletes, and Rituals
The conversation turns to Kobe Bryant, Michael Phelps, and how pre-performance routines can cue a desired identity.
[29:15] Start With Micro Habits
Charles explains why small behavior changes can compound more effectively than trying to overhaul an entire life at once.
[30:40] Charles’s First Micro Habits
Drinking less, eating fewer fries, stopping when full, and choosing healthier meals without relying on willpower.
[31:24] Feeling Full for the First Time
Charles describes the surprising experience of leaving food unfinished because his body had had enough.
[33:03] Why the Stomach Shrinks
The medication does not shrink the stomach directly; eating less over time changes how much food the body expects.
[33:21] Why Slower Stomach Emptying Helps
James asks why a weight-loss drug would slow digestion instead of speeding metabolism.
[35:00] The Cumulative Effect
Why the most visible changes often appear after several months, once habits, body size, and identity begin reinforcing each other.
[37:03] Is a GLP-1 a Lifelong Drug?
Charles explains what research and personal experience suggest about stopping, restarting, and maintaining results.
[38:56] James’s Health Motivation
James explains that his motivation is not primarily weight loss, but a desire to respond to possible pre-diabetic markers.
[39:36] Why Attitude Is Not Enough
Charles argues that wanting to be healthy helps, but habit change still requires structure.
[40:02] What Changed at Home
Charles explains how his family’s food did not need to change, even though his own choices and portions did.
[41:02] Weight, Body Composition, and Pre-Diabetes
Why blood sugar, insulin resistance, fat, and muscle matter more than the scale alone.
[42:38] Semaglutide, Tirzepatide, and What Comes Next
James and Charles compare different GLP-1 medications and discuss how newer drugs may work through multiple receptors.
[44:27] Will Charles Stop Taking It?
Charles explains why he may eventually discontinue the medication, but values having more choice over weight and behavior.
[45:24] Blood Work, Snoring, and Health Markers
Charles describes improvements in lab results, cholesterol, snoring, and overall health.
[46:31] Who Are We, Really?
James and Charles talk about identity, brain chemistry, sugar, alcohol, cravings, and the substances that shape behavior.
[48:32] Choosing the Person You Want to Become
Charles explains how better self-awareness can help people change habits deliberately rather than being pulled by cravings.
[49:00] Tracking the Experiment
Charles advises James to track food, feelings, and behavior so he can notice changes that might otherwise be invisible.
Additional Resources:
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
A Note from James:
I’ve done several hundred podcasts, but if people asked me who were the one or two people I most wanted to have on the show, Garry Kasparov would be at the top of the list. He was World Chess Champion for twenty years, and I’ve followed his career since the early ’80s.
His book, Deep Thinking, tells the story of his matches against Deep Blue, but it’s really about what may be the most important relationship of this century: humans and machines.
Episode Description:
In this From the Archive episode, James talks with Garry Kasparov in his first appearance on the show. Kasparov looks back at the matches that shaped him: his comeback from a 5–0 deficit against Anatoly Karpov, the psychological side of elite competition, and his historic showdown with IBM’s Deep Blue.
They also talk about why a computer beating a world champion did not settle the question of intelligence, how technology changes the kind of work people do, and why fear of making a mistake often causes the mistake itself. Kasparov shares what chess taught him about preparation, adaptability, mentorship, and making decisions when there is no obvious right move.
This conversation was recorded in 2017; the political discussion reflects that moment in time.
What You’ll Learn:
Timestamped Chapters:
Additional Resources:
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
A Note from James:
This is a very special episode for me.
There have only been a few times in the history of this podcast when I’ve had the chance to sit down with one of my heroes. This is one of those times.
Frank Miller is one of the most important storytellers of my life. When I first picked up Batman: The Dark Knight Returns in 1986, it completely changed what I thought comics could be. This wasn’t just another Batman story. It was a revolution. Frank took Batman out of the colorful, campy world I grew up with and turned him into something darker, mythic, terrifying, and psychologically real.
There is a comic book industry before The Dark Knight Returns, and there is a comic book industry after The Dark Knight Returns. Every Batman movie since then carries Frank’s fingerprints in some way. But it wasn’t just Batman. Frank changed Daredevil. He created Ronin. He created Sin City. He showed that comics could handle adult stories, painful arcs, crime, tragedy, mythology, obsession, and moral ambiguity.
But what matters most to me is that Frank is a master storyteller. And I love storytelling. Whether it’s books, podcasts, articles, comics, or just how we make sense of our lives, story is everything.
So getting to sit down with Frank Miller and talk about Batman, myth, creativity, mentorship, discipline, and his new book, Push the Wall: My Life, Writing, Drawing, and the Art of Storytelling, was a dream come true.
This was my first in-person podcast in years. Jay drove up from Atlanta. I flew into the city. And yes, I brought my copy of The Dark Knight Returns for Frank to sign.
Episode Description:
Frank Miller didn’t just write and draw some of the most influential comics of the modern era. He changed the grammar of comics.
In this conversation, James sits down with Miller to talk about Batman: The Dark Knight Returns, Daredevil, Ronin, Sin City, and Miller’s new book, Push the Wall. The conversation begins with Batman, but quickly becomes a larger discussion about how characters become myths.
For Miller, Batman was never just a rich detective in a costume. The material was already there from the beginning: a child witnessing the murder of his parents, growing up without powers, building himself into a force through discipline, intelligence, and obsession. Miller’s goal was to pull that core truth out and make Batman stand beside older pulp and mythic figures like Zorro, The Shadow, and the hard-edged heroes of crime cinema.
James and Frank also talk about how myths are built around simple central values. Superman is hope. Batman is justice, vengeance, effort, and fear. The art is not in making those ideas complicated. The art is in placing them inside a human context so they feel emotionally true.
The discussion moves into the craft of comics itself: page layouts, panel borders, visual rhythm, and how the pictures carry most of the story. Miller reflects on the influence of Jack Kirby, Neal Adams, Denny O’Neil, Japanese samurai films, martial arts movies, Greek tragedy, Jean Giraud/Moebius, Lone Wolf and Cub, and the creative power of combining worlds that do not obviously belong together.
They also talk about mentorship. Miller describes calling Neal Adams from the phone book, bringing him drawings, and enduring brutally honest criticism. That toughness, he says, was part of the training. To survive as an artist, you need egoism without egotism: enough belief to keep coming back, but enough humility to keep learning.
The episode closes with practical advice for young artists today: go to conventions, build the strongest portfolio you can, seek out hard criticism, don’t chase only the biggest titles, protect your original ideas, and look for “losers” you can make great.
What You’ll Learn:
Timestamped Chapters:
Additional Resources:
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
A Note from James:
I’ve been obsessed with anti-aging and longevity science for a long time. I’ve had many longevity researchers on the podcast, but this episode feels different because something we’ve been discussing for years has now moved into human trials.
David Sinclair first came on the show in 2019, when his book Lifespan was published. He’s a professor of genetics at Harvard Medical School, and that first conversation changed how I lived. I started experimenting with intermittent fasting, paid much more attention to sleep, and began researching many of the supplements and lifestyle changes he discussed.
But the most important idea David talked about wasn’t a supplement. It was the possibility of reversing cellular age using Yamanaka factors—genes that can reset the instructions cells use to function. At the time, nobody knew whether this could be done safely without causing cancer or making cells lose their identities.
Now, a therapy based on three of those factors has entered its first human clinical trial. The initial target is age-related damage to the optic nerve, including open-angle glaucoma and non-arteritic anterior ischemic optic neuropathy. The trial is designed primarily to evaluate safety, but researchers will also measure visual function.
David explains how this technology worked in mice and nonhuman primates, why the eye was chosen as the first organ, and how the same approach might eventually be applied to the liver, lungs, joints, skin, and brain.
We also cover the practical questions people always ask him: NMN, NAD, metformin, berberine, testosterone, growth hormone, diet, fasting, sleep, exercise, and what David himself has started—or stopped—taking.
This is still experimental science. Nobody yet knows whether the animal results will translate into meaningful benefits for humans. But for the first time, researchers are beginning to test that question directly.
About Lifespan:
Dr. David Sinclair founded Lifespan to deliver clear, science-backed health insights that help people live longer, more vibrant lives.
He's now building the world's largest community dedicated to extending human longevity well beyond today’s limits. Join early access at lifespan.com.
New episodes of Lifespan with Dr. David Sinclair -- the #1 health and wellness podcast in its first season -- are now available on YouTube, Spotify, Apple Podcasts, and Lifespan.com.
Episode Description:
For years, longevity researchers have looked for ways to slow the biological processes associated with aging. Dr. David Sinclair and his collaborators are now testing a more ambitious possibility: whether damaged human cells can be restored to a younger, more functional state.
The experimental therapy, ER-100, uses controlled expression of three transcription factors—OCT4, SOX2, and KLF4, collectively known as OSK. These are three of the four Yamanaka factors originally used to transform adult cells into pluripotent stem cells.
Turning on all four factors can erase too much of a cell’s identity and has produced tumors and fatal outcomes in animal experiments. Sinclair’s team found that removing one factor, c-MYC, allowed cells to regain younger patterns of gene expression without completely returning to a stem-cell state.
In preclinical studies, OSK restored youthful epigenetic patterns, promoted optic-nerve regeneration, and reversed vision loss in mouse models. Life Biosciences, a company Sinclair co-founded, has now moved the technology into a first-in-human Phase 1 trial involving people with open-angle glaucoma or non-arteritic anterior ischemic optic neuropathy.
David explains how the therapy is delivered directly into the eye and activated using doxycycline, allowing clinicians to control when and for how long the genes are expressed. He also describes the development path that could follow if the treatment proves safe, including therapies targeting the liver and other organs, as well as future medicines that may reproduce similar effects without gene delivery.
The conversation then turns to interventions available today. David distinguishes between promising research and claims that have moved ahead of the evidence, discussing NMN, injected NAD, growth hormone, testosterone, taurine, nattokinase, metformin, berberine, and nootropics.
Throughout the episode, he emphasizes that no supplement has been shown to reproduce the effects researchers are attempting to achieve through partial epigenetic reprogramming—and that many of the most dramatic claims circulating online remain unsupported.
Editorial Note:
ER-100 is an investigational therapy. Authorization to begin a clinical trial does not mean the treatment has been proven safe or effective, nor has it been approved for clinical use.
The Phase 1 study is primarily evaluating safety and tolerability, with additional measurements of visual function. Results from mice and nonhuman primates do not establish that the therapy will restore vision or reverse biological aging in people.
The discussion of supplements, prescription medications, hormones, and lifestyle practices reflects the speakers’ personal views and interpretation of the research. It should not be treated as individualized medical advice. Prescription drugs, hormones, supplements, and experimental longevity treatments should be discussed with an appropriately qualified healthcare professional.
What You’ll Learn:
Timestamped Chapters:
Additional Resources:
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Episode Description:
Prediction markets allow people to trade contracts tied to real-world events—from elections and weather to rocket launches, airport traffic, awards, and the words a public figure might use during a speech.
But James argues that having an opinion isn’t enough. Betting on your favorite team, preferred candidate, or a vague feeling about what might happen is speculation without an edge. His rule is simple: only participate when you believe you have an unfair advantage.
In this solo episode, James explains the two advantages he looks for. The first comes from understanding how prediction-market participants behave—especially their tendency to overlook outcomes that appear almost certain because the potential payout looks small. The second comes from researching a particular market more thoroughly than the other participants.
He walks through three trades he made: whether the U.S. government will confirm the existence of extraterrestrial life before 2027, whether SpaceX will exceed a specified number of June launches, and whether Donald Trump will use the phrase “movie star” during an upcoming speech. He also examines TSA passenger data to show why good research sometimes leads to the most important decision of all: not making the trade.
The larger lesson is not that any outcome is guaranteed. It is that a repeatable process—researching the data, comparing your estimated probability with the market price, diversifying, and walking away when the edge is unclear—is more useful than betting on instinct.
Editorial Note:
Prediction-market contracts are speculative and can result in the loss of the full amount committed to a position. Short-term returns expressed on an annualized basis are hypothetical comparisons, not guarantees that the same opportunity can be repeated throughout a year. This episode is educational and reflects James’s personal reasoning, not individualized financial advice.
What You’ll Learn:
Timestamped Chapters:
Additional Resources:
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
A Note from James:
Mark Pincus is one of the true OGs of the internet. You probably know him as the founder of Zynga, the company behind FarmVille, Zynga Poker, and Words With Friends. Zynga was eventually acquired by Take-Two in a transaction valued at approximately $12.7 billion. Before Zynga, Mark started Tribe, one of the first social networks—before MySpace and Facebook.
He has spent more than 25 years building, failing, and studying what gets millions of people to click, play, share, and come back. His new book, Life at the Speed of Play, inspired me to start coming up with new business ideas while we were still recording.
What I really love is how Mark teaches people to copy like a master without looking like a copycat. He has a framework called “Proven–Better–New.” Start with something that has already been proven. Make it obviously better. Then isolate the new idea you want to test. It’s one of the best systems I’ve heard for creating products people actually want.
We talk about the early days of Facebook and MySpace, the failure of Tribe, the gaming industry, consumer psychology, AI coding, and how agents could eventually network and work for us while we’re doing something else.
I loved talking with Mark. I was still thinking about this conversation afterward—and I’m literally building businesses based on what I learned. His new book is called Life at the Speed of Play. Listen to this episode, and then read the book.
Episode Description:
Most founders begin with an idea and then spend months—or years—trying to prove that people want it. Mark Pincus thinks that process is backward.
At Zynga, Mark’s teams built “failure machines”: simple systems that allowed them to test hundreds of concepts before writing the code. They put unfinished ideas in front of real users, watched what people clicked, and refused to build anything until the demand was obvious. The objective wasn’t to avoid failure. It was to make failure fast, cheap, and useful.
Mark explains the framework behind that process: Proven–Better–New. First, study an existing success down to every screen, click, and design decision. Then identify one improvement that current users would immediately recognize as better. Only after that should a team add the unproven idea—the part most likely to fail.
James and Mark also examine the problems facing today’s consumer entrepreneurs. AI has made software easier to build, but distribution has become harder. People aren’t searching for new apps, established platforms restrict organic growth, and algorithmic reach isn’t the same as users actively sharing something with friends.
Mark uses the failure of his early social network, Tribe, to explain why virality is not enough. Tribe grew quickly but lacked retention and trust. He ignored the communities users loved because they didn’t match the business model he had already chosen. That painful mistake became the foundation for much of his later product philosophy.
The conversation ends with Mark’s current experiments: personal AI agents modeled after members of his family, a proposed work network built specifically for agents, an enterprise AI company called Hivemind, and the difficult decision to end a four-year passion project without abandoning the instinct behind it.
This is a practical conversation about testing ideas, separating instinct from ego, learning from the past, and killing the wrong product before it consumes the right opportunity.
What You’ll Learn:
Timestamped Chapters:
Additional Resources:
Mark Pincus and the Book
Zynga, Games, and Product Examples
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
A Note from James:
If I could tell my children to read one post of mine, it would be this post.
Influence is how they will navigate a world of uncertainty.
Robert Cialdini is the most influential person in the world. And by that I mean, he wrote the book Influence, which sold 3 million copies and defines the six critical aspects of all influence.
Now he has a new book, Pre-Suasion, going 10x deeper into the concepts of persuasion. I got him on my podcast so I could ask the 1,000 questions I have.
Small story from the book:
If you name a restaurant “Studio 97” instead of “Studio 17,” people are more likely to tip higher.
If you ask a girl for her phone number outside a flower store, triggering feelings of romance, she is more likely to give it to you than if you ask her outside a motorcycle store.
And 500 other stories.
The environment is just as important as what you say.
Before the podcast began, I gave him a book as a gift: The Anxiety of Influence, a history of poetry.
What would poetry have to do with influence and marketing?
In all art, since the beginning of time, artists have built on the work of the artists of the generation before them.
Beethoven depended on a Mozart to be a Beethoven. Picasso depended on a Cézanne. Without Michelson, there would be no Einstein.
But poets, for some reason, would deny being influenced.
“I never even read Ezra Pound,” shouted one poet at a critic.
Poets want to be seen as original.
Nobody is 100% original.
This is the anxiety of influence.
Almost all of our decisions, and even our creativity, are outsourced to the people around us who influence us: peers, teachers, religion, parents, bosses, etc.
Our personality is our own particular mishmash of influences.
How we deal with that anxiety, how we recognize the influences, learn from them, and build from them, is the birth of all of our creativity.
Let me summarize the seven aspects of influence:
I’ve used each of the above in business.
They work.
They will make you money.
The entire purpose of language is to influence.
We are not strong animals. We are weak.
The language of influence saved us.
Probably a word like “Run!” was the first word spoken.
A word of influence.
And it worked.
I’m still running from the things I fear.
So speak to influence.
Don’t speak to call a flower yellow.
Speak to breathe spirit into an idea, to be enthusiastic, to convey emotion, to influence.
This is the only way to have an impact with your unique creativity.
I gave Robert the book as a gift — reciprocity — assuming we would have a great podcast.
And we did.
But then I thought later, I can’t even remember how Robert got on my podcast.
I highly recommend his book in the podcast and even in this post.
As he got into his car after the podcast in order to go to his next interview, I started thinking:
“Hmmm, who influenced who?”
Episode Description:
Robert Cialdini wrote the book on persuasion — literally. His classic Influence became one of the defining books on why people say yes, how decisions get shaped, and why the smallest cue in the room can change the outcome of a conversation.
In this episode from the archive, James talks with Cialdini about Pre-Suasion, the idea that persuasion starts before the actual pitch. It begins with what people notice, what they feel, what is in the environment, and what frame has already been set before the first real ask is made.
They talk about flower shops, restaurant names, voting booths, Warren Buffett’s shareholder letters, Anwar Sadat’s negotiation instincts, and the rabbi who helped save thousands of lives with one sentence. But the episode is not just about marketing. It is about how people make decisions under uncertainty — and how to use influence ethically, whether you are asking for a job, building a business, negotiating a deal, writing a sales letter, or trying to become more trusted.
What You’ll Learn:
Timestamped Chapters:
Additional Resources:
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Episode Description:
In this episode from the early days of The James Altucher Show, James sits down with T. Harv Eker, author of Secrets of the Millionaire Mind, to examine why earning money, keeping money, and feeling secure about money are three very different skills.
Harv recounts cycling through 14 jobs and 12 businesses before building a successful chain of fitness stores—and then losing much of what he had earned. That experience forced him to confront what he calls a person’s “money blueprint”: the beliefs about wealth, work, success, and self-worth that are often absorbed long before we recognize them.
Although this conversation was originally recorded years ago, Harv’s advice still applies today. He explains how to separate your identity from your financial results, challenge inherited beliefs, create income that does not depend entirely on your time, and recognize the thoughts that quietly keep you inside your comfort zone.
What You’ll Learn:
Timestamped Chapters:
Additional Resources:
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
A Note from James:
Oh my gosh, one of my favorite guests ever: Ben Mezrich.
Ben wrote Bringing Down the House, which became the movie 21. He wrote The Accidental Billionaires, which became The Social Network. And now his latest page-turner, Checkmate, is about one of the most explosive scandals in modern sports: the Hans Niemann chess cheating controversy that took over the world.
You remember the story. Magnus Carlsen, the greatest chess player of all time, loses to this completely arrogant, egotistical 19-year-old bad boy of chess. Then Magnus accuses him of cheating. This had basically never happened before at that level in chess.
What followed was a viral meltdown: the infamous anal beads tweet, death threats, lawsuits, chess.com, Netflix documentaries, and a chess world at war with itself.
Ben spent over a year with Hans Niemann. He got access to Magnus’s camp, chess.com, and the drama behind the chessboards. So we talk about whether Hans actually cheated that day, the insane rise of online chess during COVID, the world of prodigies, the generational clash inside elite chess, and how one suspicious game nearly destroyed a young player’s career.
So welcome to one of my favorite guests, Ben Mezrich.
Episode Description:
James talks with bestselling author and screenwriter Ben Mezrich about Checkmate, his new book on the Magnus Carlsen–Hans Niemann chess cheating scandal. It’s classic Mezrich territory: brilliant young people, high-stakes competition, huge money, a gray area between genius and rule-breaking, and a story that becomes much bigger than the facts alone.
The conversation is especially strong because James knows the chess world firsthand. He was a master-level player, helped build early internet chess infrastructure, knows many of the top players, and has commentated on Norway Chess. That gives the interview a different texture: Ben brings the reporting and the narrative access, while James brings the chess context and the ability to test the story move by move.
They talk about Hans’s rise, Magnus’s suspicion, chess.com’s cheating algorithms, why online cheating is different from over-the-board cheating, the role of the infamous anal beads tweet, and the psychological cost of being publicly accused without definitive evidence. The question underneath the whole episode is not just “Did Hans cheat?” It’s: what happens when reputation, genius, technology, money, and suspicion all collide on one chessboard?
What You’ll Learn:
Timestamped Chapters:
Additional Resources:
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
From the publisher's feed
Ranked by our users in the last 21 days

16,045 Listeners

3,310 Listeners

2,713 Listeners

7,188 Listeners

4,977 Listeners

2,187 Listeners

4,693 Listeners

7,911 Listeners

4,942 Listeners

2,639 Listeners

28,980 Listeners

590 Listeners

1,061 Listeners

17 Listeners

250 Listeners